HDAC9 and liver cancer: Accordingly, we treated with low-dose C2 ceramide to activate PP1 without cell apoptosis and autophagy activation and siRNA to confirm PP1 play an important role in the chemosensitivity of liver cancer cells and HDAC inhibitors resistance cells.